# Medium vs Low Oxygen Threshold for the Surfactant Administration

> **NCT04199364** · PHASE4 · UNKNOWN · sponsor: **Virgilio Paolo Carnielli** · enrollment: 200 (estimated)

## Conditions studied

- Respiratory Distress Syndrome

## Interventions

- **DRUG:** Poractant Alfa 80 mg/mL Intratracheal Suspension

## Key facts

- **NCT ID:** NCT04199364
- **Lead sponsor:** Virgilio Paolo Carnielli
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2024-07-01
- **Final completion:** 2025-04-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04199364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04199364, "Medium vs Low Oxygen Threshold for the Surfactant Administration". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04199364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*